Konstantinos Katogiannis

Athens, ESYE31 12462, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Effects of Nutritional Supplements on Vascular Function: A Narrative Review.

Effects of Nutritional Supplements on Vascular Function: A Narrative Review.

Journal: Journal of clinical medicine

Published: June 05, 2026

Coronary Flow Reserve in Adults: Pathophysiology, Assessment Modalities, Clinical Applications, and Prognostic Significance.

Coronary Flow Reserve in Adults: Pathophysiology, Assessment Modalities, Clinical Applications, and Prognostic Significance.

Journal: Medicina (Kaunas, Lithuania)

Published: April 18, 2026

Differences in Endothelial Glycocalyx, Arterial Stiffness, and Left Atrial Function Among Ischemic Stroke Types.

Differences in Endothelial Glycocalyx, Arterial Stiffness, and Left Atrial Function Among Ischemic Stroke Types.

Journal: Thrombosis and haemostasis

Published: March 16, 2026

MiniMedTM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics.

MiniMedTM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics.

Journal: Diabetes technology & therapeutics

Published: February 06, 2026

GLP-1 receptor agonists, SGLT-2 inhibitors, and their combination: effects on carotid atherosclerosis regression, oxidative stress, and amyloid-β1-40 in diabetes.

GLP-1 receptor agonists, SGLT-2 inhibitors, and their combination: effects on carotid atherosclerosis regression, oxidative stress, and amyloid-β1-40 in diabetes.

Journal: American journal of physiology. Heart and circulatory physiology

Published: January 24, 2026

Vascular and Myocardial Function in Patients with Type 2 Diabetes and Ischemic Stroke Treated with Dulaglutide or Empagliflozin.

Vascular and Myocardial Function in Patients with Type 2 Diabetes and Ischemic Stroke Treated with Dulaglutide or Empagliflozin.

Journal: Medicina (Kaunas, Lithuania)

Published: December 27, 2025

Air Travel in Patients with Acute Coronary Syndromes or Heart Failure: Current Evidence, Guidance and Gaps.

Air Travel in Patients with Acute Coronary Syndromes or Heart Failure: Current Evidence, Guidance and Gaps.

Journal: European heart journal. Quality of care & clinical outcomes

Published: December 12, 2025

Effects of dapagliflozin and dulaglutide on blood pressure and coronary flow in liver steatosis patients with type 2 diabetes.

Effects of dapagliflozin and dulaglutide on blood pressure and coronary flow in liver steatosis patients with type 2 diabetes.

Journal: Journal of hypertension

Published: August 09, 2025

Association of Endothelial Glycocalyx Integrity with Left Ventricular Performance and Remodeling after Acute Myocardial Infarction: A 12-month Follow-up Study.

Association of Endothelial Glycocalyx Integrity with Left Ventricular Performance and Remodeling after Acute Myocardial Infarction: A 12-month Follow-up Study.

Journal: Thrombosis and haemostasis

Published: July 10, 2025

The effects of cytisinicline for smoking cessation on arterial stiffness, endothelial function, and myocardial performance: a pilot study.

The effects of cytisinicline for smoking cessation on arterial stiffness, endothelial function, and myocardial performance: a pilot study.

Journal: European heart journal. Imaging methods and practice

Published: June 05, 2025

The Beneficial Effects of Combination Therapy With SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus.

The Beneficial Effects of Combination Therapy With SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus.

Journal: Current diabetes reviews

Published: June 01, 2025

Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes.

Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes.

Journal: Journal of the American Heart Association

Published: February 26, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026